Phase II clinical evaluation of doxifluridine.
Hurteloup P, Armand JP, Cappelaere P, Metz R, Kerbrat P, Keiling R, Fumoleau P, Fargeot P, Schraub S, Bastit P, et al.
Hurteloup P, et al. Among authors: keiling r.
Cancer Treat Rep. 1986 Jun;70(6):731-7.
Cancer Treat Rep. 1986.
PMID: 2942245